• Understanding Histio
    • Overview of Histiocytic Disorders
    • Hemophagocytic Syndromes
    • Langerhans cell Histiocytosis in Adults
    • Langerhans Cell Histiocytosis in Children
    • Pulmonary Langerhans Cell Histiocytosis
    • Erdheim-Chester Disease
    • Rosai-Dorfman Disease
    • Xanthogranuloma
    • Malignant Histiocytosis
    • Diabetes Insipidus/Arginine Vasopressin Deficiency
  • Research
    • The Road to a Cure
    • Annual Funding Process
    • Registries, Clinical Trials, & Genomic Sequencing
    • Grants Awarded
    • Funding Opportunities
  • Resources
    • Resource Overview
    • Physician Finder
    • Resource Directory
    • Education & Peer Connection
      • Educational Video Series
      • Webinars
      • Peer Connection
      • Regional Meetings
      • Beyond The Diagnosis Podcast
      • Yoga For Histio
    • Scholarship Program
      • Student Scholarship Program
      • Ingrassia Early Career Travel Scholarship
  • Who We Are
    • About the Association
    • Blog
    • Impact & Financials
    • Histio Ambassadors
    • Partnerships & Sponsors
    • Organizational History
    • Contact the Association
  • Get Involved
    • Donate
    • How to Get Involved
    • Raise Awareness
    • Fundraising Events
    • Other Ways to Give
    • Annual Campaigns
    • Job & Volunteer Opportunities
    • eStore
Donate

HLH/FEL/FHL

Mechanism of Interferon Gamma Induced Liver Sinusoidal Endothelial Cell Disruption in Familial Hemophagocytic Lymphohistiocytosis Hepatitis

Evaluation of the Bromodomain and Extra Terminal (BET) Domain Activity as an actionable Target in Hemophagocytic Lymphohistiocytosis (HLH)

Validation and Implementation of a Novel Tool for Predicting Pathogenicity of Variants of Uncertain Significance in Familial Hemophagocytic Lymphohistiocytosis Genes

Prime editing-based correction of UNC13D

Evaluation of protein arginine methyltransferase 5 (PRMT5) as an actionable target in hemophagocytic lymphohistiocytosis (HLH)

DOCK Genes: Novel Risk Alleles for Cytokine Storm Syndrome

Defining the pathophysiology of HLH in Hematologic Malignancies

Defining and Testing the Hyperinflammatory Immune Synapse

Immunoproteasome inhibition as a novel therapy for hemophagocytic lymphohistiocytosis (HLH)

Role of the immune checkpoint TIM-3 in the pathogenesis of non-classical HLH

1 2 3 4 … 8 Next

Histiocytosis Association, Inc.

332 North Broadway, Pitman, New Jersey 08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
Email: info@histio.org
US & Canada Toll-Free: 1-800-548-2758
Tax ID: 22-2827069
Privacy Policy

Make a Donation today

Stay Connected to the Histio Community

Sign Up for Our Newsletter
Facebook
X
Instagram
YouTube

© 2026 Histiocytosis Association, Inc., All Rights Reserved.

  • Symptoms
  • Diagnosis & Treatment
  • Resources
  • FAQ
  • What Do I Do Now?